You are here

Article Text

Article menu

Download PDFPDF

Primary Survey
Primary Survey
Free
  1. Pete Driscoll,
  2. Jim Wardrope, Joint Editors

    https://doi.org/10.1136/emj.19.6.488-a

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      LOW DOSE NALBUPHINE TREATMENT DOES NOT PRODUCE ADEQUATE ANALGESIA IN PREHOSPITAL CARE

      Nalbuphine hydrochloride was, until recently, the only intravenous analgesic authorised for use by paramedics. While the manufacturer's datasheet provides guidelines on dosing regimens, in practice these vary in each ambulance Trust. We sought to determine if a low dose regimen, designed to minimise the incidence of respiratory depression, was safe and effective. We found side effects were rare and not clinically significant, but that the regimen resulted in inadequate analgesia in a high proportion of patients. Larger incremental doses delivered over shorter intervals should be adopted. However, these may risk increasing the incidence of side effects, and further research is required to determine the optimal regimen. See page565

      CHRONIC PAIN AFTER WHIPLASH INJURY

      Whiplash injury is common. Yet, many physicians …

      View Full Text

      Linked Articles